Loading
Life sciences · Observational Study
ClinicalTrials.gov · September 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06896266). This is a study registration, not published results. Lead sponsor: Hospital Universitario 12 de Octubre. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 109 participants (ESTIMATED). Conditions: Arrhythmia, Cardiomyopathy, Arrhythmia-induced Cardiomyopathy (AiCM). Primary outcome measures: Prevalence of pathogenic or likely pathogenic variants in genetic test , Through study completion, an average of 1 year. Brief summary: The goal of this observational study is to learn about the genetic insights of arrhythmya-induced cardiomyopathy and its clinical prognosis. The main questions it aims to answer are: I. Does patients with arrhythmia-induced cardiomyopathy have a greater proportion of genetic mutations compared with other types of cardiomyopathy or general population? II. Have the genetics any prognostic impact in patients with arrhythmia-induced cardiomyopathy?